Vulva Cancer Screening: How It Works, Results and What to Expect

Vulva cancer screening is not a routine population test like cervical screening. Instead, clinicians assess the vulva during pelvic or gynecologic examinations and investigate persistent skin or tissue changes with a biopsy when needed.

Overview: What Vulva Cancer Screening Means

Vulva cancer screening usually means checking the external genital area for unusual changes during a gynecologic visit and arranging further tests when a finding needs evaluation. There is currently no recommended routine screening test for vulvar cancer for the general population who have no symptoms. A cervical screening test, including a Pap test or HPV test, checks the cervix and does not screen for vulvar cancer.

The vulva includes the external female genital structures, such as the labia, clitoris, and vaginal opening. Most vulvar cancers are squamous cell carcinomas, which begin in skin cells. They are uncommon, and many vulvar symptoms are caused by noncancerous conditions, including irritation, infection, cysts, or inflammatory skin disorders. However, a change that persists or does not respond to usual care deserves medical assessment.

The goal is not to cause worry but to recognize changes early. A clinician can examine the skin and surrounding tissues, discuss symptoms and risk factors, and take a small tissue sample if necessary. Pathology examination of that sample is the only reliable way to diagnose vulvar cancer.

Who May Need a Vulvar Examination

Anyone can request a vulvar examination if they notice a new or ongoing change. It may also be included as part of a routine gynecologic assessment, particularly when a person has symptoms. Self-awareness is useful: knowing what is normal for the individual can make it easier to notice a new lump, sore, patch of thickened skin, or change in color.

Clinicians may recommend closer monitoring for people with a history of vulvar precancer, vulvar cancer, persistent HPV-related disease, or chronic vulvar skin conditions such as lichen sclerosus. A weakened immune system, smoking, and increasing age can also raise risk. These factors do not mean that cancer will develop, but they can influence how promptly changes are assessed and how often follow-up is advised.

People who have had cervical, vaginal, or anal HPV-related abnormalities may benefit from discussing vulvar symptoms and examination with their gynecologist. HPV vaccination can help prevent infections with HPV types linked to several cancers, but it does not replace evaluation of new symptoms or recommended cervical screening.

How Vulva Cancer Screening Works: Step by Step

A vulvar assessment begins with a conversation. The clinician may ask when symptoms started, whether they have changed, whether there is itching, pain, bleeding, discharge, or difficulty passing urine, and whether there is a personal history of skin conditions or HPV-related disease. It is helpful to mention any creams, treatments, or medicines already tried.

During the examination, the person lies comfortably on an examination table while the clinician inspects the vulva in good lighting. They may gently feel the area and, when appropriate, examine the vagina, cervix, and groin lymph nodes. A speculum examination may be needed for a complete gynecologic assessment, but it is not always required solely to inspect the vulva.

If a specific area looks unusual, the clinician may use magnification, sometimes called vulvoscopy, and apply a mild solution to better define surface changes. This can guide the choice of biopsy site. The examination itself is usually brief, and the patient can ask for an explanation at each stage or request a pause if uncomfortable.

When a biopsy is advised, local anesthetic is used to numb the area. A small sample is removed and sent to a laboratory, where a pathologist examines it under a microscope. Depending on the finding, the clinician may arrange further assessment through gynecologic oncology care or refer the patient to a specialist with experience in vulvar conditions.

Results, Biopsy Findings, Benefits and Possible Risks

A normal examination is reassuring, but it does not prevent a person from seeking care later if a new symptom appears. If a biopsy is performed, results may show a benign skin condition, inflammation, infection, a precancerous change, or cancer. Results are commonly available after the laboratory has processed and reviewed the tissue; the exact timing varies by health system and testing requirements.

Precancerous vulvar changes are sometimes described as vulvar intraepithelial neoplasia or differentiated vulvar intraepithelial neoplasia. These findings are not invasive cancer, but they may need treatment or close surveillance because some can progress over time. The recommended plan depends on the pathology result, the area involved, symptoms, and the person’s overall health.

The main benefit of examination and targeted biopsy is accurate diagnosis. Detecting a concerning lesion early can allow more focused treatment and may reduce the extent of surgery needed. The main limits are that visual appearance is not definitive and some skin changes can resemble one another, which is why pathology is important.

Biopsy risks are generally small but can include temporary soreness, minor bleeding, bruising, infection, or delayed healing. Keeping the area clean, following the clinician’s wound-care instructions, and reporting fever, increasing pain, spreading redness, foul-smelling discharge, or ongoing bleeding can help support safe recovery.

How Fast Does Vulvar Cancer Grow?

Vulvar cancer does not grow at one predictable speed. Some vulvar precancerous conditions and cancers develop slowly over years, while others may change more quickly. Growth can depend on the cancer type, whether it is related to HPV or chronic inflammatory skin disease, immune health, and other individual factors.

Because the pace cannot be judged reliably from symptoms or appearance, a persistent or changing lesion should not be watched indefinitely at home. A clinician can decide whether it is reasonable to monitor an area, treat a noncancerous condition first, or perform a biopsy promptly.

Early assessment does not mean a diagnosis of cancer is likely. It means that potentially important changes can be identified accurately and managed at the appropriate time. For people with known precancerous vulvar changes, keeping follow-up appointments is particularly important.

What Does Stage 1 Vulvar Cancer Look Like?

Stage 1 vulvar cancer is cancer that is limited to the vulva or nearby perineal tissues and has not spread to lymph nodes or distant sites. It may appear as a small lump, wart-like growth, thickened patch, ulcer or sore that does not heal, or an area that is white, red, darkened, or otherwise different from the surrounding skin. It can also cause itching, burning, tenderness, bleeding, or pain, although some people have few symptoms.

There is no single appearance that identifies stage 1 disease. A lesion can look similar to a benign condition, and a small lesion is not automatically early-stage cancer. Staging depends on biopsy results and, when cancer is confirmed, the size and depth of invasion as well as assessment for any spread.

For this reason, photographs, online descriptions, and self-examination cannot establish a stage or diagnosis. A gynecologist or gynecologic oncologist can assess the area and recommend the appropriate tests. Related information about vulvar cancer may help patients understand the condition after a diagnosis or specialist referral.

Can a Gynecologist See Vulvar Cancer? How Is Stage 1 Diagnosed?

A gynecologist can often see or feel changes that could be vulvar cancer during a clinical examination. They can identify a suspicious lesion, document its location, and arrange testing. However, they cannot confirm cancer based on appearance alone because noncancerous skin conditions may look similar.

Stage 1 vulvar cancer is diagnosed through a biopsy showing invasive cancer, followed by clinical assessment and, when needed, imaging or other tests to determine the cancer’s extent. The pathology report provides key information, including the cancer type and depth of invasion. A specialist team then uses these findings to assign the stage and discuss treatment options.

Treatment for confirmed early vulvar cancer commonly focuses on removing the cancer while preserving function and normal tissue where possible. Depending on the lesion and lymph-node risk, care may include local excision and assessment of sentinel lymph nodes. Sentinel lymph node biopsy may be considered for selected patients to check whether cancer cells have reached the first draining lymph nodes.

After a simple biopsy, mild tenderness or spotting may last a few days. Most people can return to usual light activities quickly, but should avoid friction, sexual activity, swimming, or products on the area for the period advised by their clinician. More extensive procedures have individualized recovery plans.

When to Seek Medical Care

A person should arrange a gynecologic appointment if they notice itching that lasts more than a few weeks, a new lump or growth, a sore that does not heal, persistent pain or burning, unexplained bleeding, changes in skin color or texture, or a change in a longstanding vulvar lesion. These symptoms are often due to conditions other than cancer, but an examination is the safest way to understand the cause.

More urgent assessment is appropriate for heavy bleeding, severe pain, rapidly worsening swelling, fever with signs of infection after a biopsy, or difficulty passing urine. A clinician can advise whether same-day care is needed based on the symptoms and medical history.

There is no proven home test for vulvar cancer. Gentle vulvar skin care, avoiding irritants when symptoms are present, not smoking, receiving recommended HPV vaccination, and attending follow-up for diagnosed skin conditions are practical preventive steps. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals provide diagnostic assessment and treatment planning for international patients with vulvar concerns.

Frequently asked questions

Is there a routine screening test for vulvar cancer?

No. There is no standard routine screening test for vulvar cancer in people without symptoms or concerning findings. Vulvar cancer is usually identified through a clinical examination and confirmed with a biopsy of an abnormal area.

Does a Pap test detect vulvar cancer?

No. A Pap test examines cells from the cervix and is used in cervical cancer screening. It does not examine vulvar skin or rule out vulvar cancer, so new vulvar symptoms should be assessed separately.

How is a vulvar biopsy performed?

A clinician first numbs the area with local anesthetic, then removes a small piece of tissue from the area of concern. The sample is examined by a pathologist, and temporary soreness or slight bleeding may occur afterward.

Can vulvar cancer be mistaken for a skin condition?

Yes. Vulvar cancer can resemble inflammatory skin conditions, infections, cysts, warts, or irritation. This is why persistent or changing lesions may need a biopsy rather than diagnosis based on appearance alone.

What happens if a vulvar biopsy shows precancer?

The clinician will explain the specific type of precancerous change and recommend treatment or surveillance based on the pathology result and individual circumstances. Follow-up is important because some precancerous changes can persist or progress if untreated.

Can vulvar cancer be prevented?

Not every case can be prevented, but HPV vaccination, avoiding tobacco, and ongoing care for chronic vulvar skin conditions may lower risk for some people. Prompt assessment of persistent vulvar changes supports early diagnosis.

References

• World Health Organization
• American Cancer Society
• National Cancer Institute
• American College of Obstetricians and Gynecologists
• International Agency for Research on Cancer

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.